Patent details
EP2654755 Title: Combination therapy comprising Gemcitabine for the treatment of pancreatic cancer
Basic Information
- Publication number:
- EP2654755
- PCT Application Number:
- PCT/US/2011/066017
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP118510460
- PCT Publication Number:
- WO/2012/088030
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Combination therapy comprising Gemcitabine for the treatment of pancreatic cancer
- French Title of Invention:
- Thérapie combinatoire comprenant Gemcitabine pour traiter le cancer du pancréas
- German Title of Invention:
- Kombinationstherapie mit Gemcitabin zur Behandlung von Bauchspeicheldrüsenkrebs
- SPC Number:
Dates
- Filing date:
- 20/12/2011
- Grant date:
- 17/08/2016
- EP Publication Date:
- 17/08/2016
- PCT Publication Date:
- 28/06/2012
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 30/10/2013
- EP B1 Publication Date:
- 17/08/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 20/12/2016
- Expiration date:
- 20/12/2031
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/12/2011
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- DEMARINI Douglas, J.
- Address:
- United States (US)
2
- Name:
- LE Ngocdiep, T.
- Address:
- United States (US)
Priority
- Priority Number:
- 201061424961
- Priority Date:
- 20/12/2010
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/519;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|